Upon completion of this activity, participants should be able to:
- Describe the pleiotropic mechanism of action of GLP-1 receptor agonists.
- Discuss efficacy and safety data for approved GLP-1 receptor agonists, including efficacy for glycemic and extra-glycemic effects.
- Incorporate GLP-1 receptor agonists into evidence-based individualized management plans for patients with type 2 diabetes aligned with current guideline recommendations.